KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Revenue: 2009-2024

Historic Revenue for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $277.2 million.

  • Dynavax Technologies' Revenue rose 17.67% to $94.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.5 million, marking a year-over-year increase of 26.73%. This contributed to the annual value of $277.2 million for FY2024, which is 19.36% up from last year.
  • Latest data reveals that Dynavax Technologies reported Revenue of $277.2 million as of FY2024, which was up 19.36% from $232.3 million recorded in FY2023.
  • Dynavax Technologies' Revenue's 5-year high stood at $722.7 million during FY2022, with a 5-year trough of $46.6 million in FY2020.
  • Its 3-year average for Revenue is $410.7 million, with a median of $277.2 million in 2024.
  • In the last 5 years, Dynavax Technologies' Revenue soared by 844.00% in 2021 and then plummeted by 67.86% in 2023.
  • Dynavax Technologies' Revenue (Yearly) stood at $46.6 million in 2020, then skyrocketed by 844.00% to $439.4 million in 2021, then skyrocketed by 64.45% to $722.7 million in 2022, then tumbled by 67.86% to $232.3 million in 2023, then rose by 19.36% to $277.2 million in 2024.